Dexcom (DXCM) Raw Materials (2010 - 2026)

Dexcom (DXCM) has 13 years of Raw Materials data on file, last reported at $247.9 million in Q1 2026.

• On a quarterly basis, Raw Materials fell 32.27% year-over-year to $247.9 million in Q1 2026; TTM through Mar 2026 was $247.9 million, a 32.27% decrease from a year earlier, with the FY2025 full-year figure at $257.6 million, down 21.25% from the prior year.
• Raw Materials for Q1 2026 stood at $247.9 million, down from $257.6 million in the prior quarter.
• Over the last five years, Raw Materials for DXCM reached as high as $366.0 million in Q1 2025 and fell as low as $151.1 million in Q2 2022.
• Historically, Raw Materials has averaged $254.0 million across 5 years, with a median of $257.6 million in 2025.
• Across the five-year window, Raw Materials jumped 100.94% in 2023 and plunged 32.27% in 2026, its largest moves.
• Year by year, Raw Materials stood at $159.0 million in 2022, then soared by 100.94% to $319.5 million in 2023, then grew by 2.38% to $327.1 million in 2024, then decreased by 21.25% to $257.6 million in 2025, then dropped by 3.77% to $247.9 million in 2026.
• Per Business Quant data, the three most recent Raw Materials figures were $247.9 million in Q1 2026, $257.6 million in Q4 2025, and $266.0 million in Q3 2025.